BioCentury
ARTICLE | Clinical News

Anavex Life Sciences Corp preclinical data

March 30, 2015 7:00 AM UTC

In a mouse model of AD, ANAVEX 3-71 reversed synaptic loss in hippocampal neurons. ANAVEX 3-71 also reduced soluble and insoluble beta amyloid 40, beta amyloid 42, beta amyloid plaques and beta-sit...